The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.
about
A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesMolecular alterations that drive breast cancer metastasis to boneCancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer TreatmentTGF-β family signaling in stem cellsHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsHER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Predicting targeted drug combinations based on Pareto optimal patterns of coexpression network connectivityOncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.BMP-2 induces EMT and breast cancer stemness through Rb and CD44.Activin-A signaling promotes epithelial-mesenchymal transition, invasion, and metastatic growth of breast cancerCharacterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere culturesSMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.Key genes for modulating information flow play a temporal role as breast tumor coexpression networks are dynamically rewired by letrozole.Targeting cancer stem cells in solid tumors by vitamin D.Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.Bone morphogenetic protein 4 (BMP-4) and epidermal growth factor (EGF) inhibit metalloproteinase-9 (MMP-9) expression in cancer cells.Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression.Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization.Autosomal dominant mesomandibular fibro-osseous dysplasia: a self-resolving inherited fibro-osseous lesion of the jawsMolecular characteristics of cancer stem-like cells derived from human breast cancer cells.Gastric stem cells and gastric cancer stem cells.Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft modelPrimary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature.The relevance of the TGF-β Paradox to EMT-MET programsCancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance.Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma.c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expressionBMP signaling and its paradoxical effects in tumorigenesis and dissemination.The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?The role of TGF-β in bone metastasis: novel therapeutic perspectives.BMPs as therapeutic targets and biomarkers in astrocytic glioma.Regulation of breast cancer stem cell features.Bone morphogenetic protein signaling in musculoskeletal cancer.Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling.Structural Biology and Evolution of the TGF-β FamilyIsolation, identification, and characterization of cancer stem cells: A review.Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival.The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
P2860
Q26739015-8573CB82-630E-4DCA-BB11-62CCF57C7029Q26829858-4DA57B97-F09E-46A4-8A74-37F2C7790BE7Q27024816-D2392344-502B-4E61-B75F-1AFB3C2A74F3Q28274611-380C790A-9744-4D08-A9A9-B22C637CCE62Q28393898-5AA09023-46EF-4C74-B5BF-5FB9974F1E3FQ33737278-42039A68-DED9-419A-9EF2-0FA2F5C02D64Q33772585-AF6D5562-48A8-4DEB-A6F7-B8B32FE34530Q33902576-880D7C96-4A38-4EA3-8B2E-EFD405C6AF81Q33907042-003638F0-E23A-4B45-B07C-1CC358EF7DAAQ33914768-E03BC5ED-DDA6-4458-BA3D-692CDCA02504Q34361095-CA840DD9-EF48-49BC-9D7F-B922D5A63AC1Q34695105-8BBB0D4C-BE1B-460D-9650-4555AE66FF63Q34790668-96331CA8-73D1-4A31-8E8E-7DCB7928B4A5Q35181108-D78B3FDA-2153-4F25-8F14-463812DE3BA3Q35203271-007D230A-F39C-4629-9E0A-81B2119B4235Q35376245-B41B231F-7FB8-4421-A4A7-295E646C3B6BQ35822075-258F0F69-C7D6-434C-88A9-14ED8037EFB4Q36356105-B129B10D-531D-49ED-A2B1-EC8B6A1C3EB2Q36428229-753F89EA-8F75-4C53-96A6-32BF5138E031Q36449176-53ABEE83-A8AC-4195-819B-41A27BE437F4Q36693476-3FAA1CDA-8FB4-496A-80EE-732296049A70Q36737793-1AEC6815-C5CF-47F3-8AA8-972F5FF6BF48Q36835474-35049ACC-3DF8-4CA8-B899-D5A86584969AQ36959186-2DAE27B4-83CA-45BE-879E-34A662FBF845Q37118399-BDD071EC-ADD5-4771-A426-3F062E477CCFQ37441234-98949B61-48BF-471C-931D-61330C126AE0Q37571496-36623BF2-E0EB-441D-8044-EB4C72411943Q37684429-1BF7B892-6D7F-47A1-9C10-999314E07F20Q37718513-EA30E0D0-B8CB-45C1-ABA2-82AEE134999FQ38045265-421363B8-C6E8-400A-90C5-44096AB15389Q38115632-6C2BA4D8-9CE9-46EE-812E-F04DBA4DA087Q38129383-339043D0-B0B4-4861-98FC-5F1A0A6582EFQ38216033-FA517326-C148-4667-AAC1-8C30828F0B42Q38359738-B0A0F8ED-1980-47C2-90C7-AE11519AF038Q38797636-930CC1E0-573E-48C2-BEE6-A176AA53A547Q38913330-8C676712-53D1-4FDD-9D52-BC0A396339B8Q38957057-D45D8B69-5A65-4637-8A54-820C6473B008Q39055537-FEFEFA21-08D8-4A74-8205-F548456FDA75Q39135169-2040023E-8355-4B02-8E1A-1558367C35F6Q39295657-7B1E51F6-2DBE-4E6D-A69C-A58A797C2588
P2860
The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The BMP2/7 heterodimer inhibit ...... and bone metastases formation.
@en
The BMP2/7 heterodimer inhibit ...... and bone metastases formation.
@nl
type
label
The BMP2/7 heterodimer inhibit ...... and bone metastases formation.
@en
The BMP2/7 heterodimer inhibit ...... and bone metastases formation.
@nl
prefLabel
The BMP2/7 heterodimer inhibit ...... and bone metastases formation.
@en
The BMP2/7 heterodimer inhibit ...... and bone metastases formation.
@nl
P2093
P2860
P356
P1433
P1476
The BMP2/7 heterodimer inhibit ...... and bone metastases formation.
@en
P2093
B de Rooij
C van den Hoogen
G van der Horst
G van der Pluijm
M Petersen
P G M van Overveld
R C M Pelger
P2860
P2888
P304
P356
10.1038/ONC.2011.400
P407
P577
2011-09-26T00:00:00Z
P5875
P6179
1018716706